2024 Round Table Sessions
2024 Round Table Sessions include the following topics from which participants may choose during registration:
Implications of FDA’s proposed rule regarding laboratory developed tests (LDT)
Clinical applications and guideline updates for liquid biopsy
Cancer pharmacogenomics: genomic alterations and germline variance in cancer drug resistance
Artificial Intelligence (AI) and Machine Learning (ML) in clinical genomics
Innovations in genomic technologies for low-resource settings
Laboratory automation and changes in testing practices to address laboratory workforce challenges and Workforce readiness for cancer genomic laboratories
Implications and solutions for clinical cancer genomics from racial and ancestral disparity in genomic data and research
Complex structural rearrangement analysis with novel technologies
The clinical application of whole genome/exome sequencing (WGS/WES) and long read sequencing (LRS)
Molecular-based classification of hematologic malignancy
Clinical utility of measurable residual disease (MRD) monitoring for hematopoietic neoplasms
Validation of bioinformatic pipelines
Integration of molecular and cytogenetic laboratories
DNA methylation (and gene expression) profiling for molecular subtyping
Cytogenetic workup strategy in the era of new genomic tools
Germline and somatic variant classification in cancers and clinical use of the ClinGen/CGC/VICC oncogenicity guideline in practice
Bioinformatics and data interoperability of clinical cancer genomics